MDxHealth SA (MDXH) stock
MDXHNasdaqServices-Medical Laboratories
$0.15+0.00 (0.00%)
Close on Nov 17, 2026Market cap $765.33KP/E –Yield –
MDxHealth r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $10.35M, down 1.9% from the year before. The highest annual figure on record is $10.55M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.35M | -1.9% |
| FY2024 | Dec 31, 2024 | $10.55M | +65.5% |
| FY2023 | Dec 31, 2023 | $6.38M | +16.0% |
| FY2022 | Dec 31, 2022 | $5.50M | -1.6% |
| FY2021 | Dec 31, 2021 | $5.59M | +23.0% |
| FY2020 | Dec 31, 2020 | $4.54M | -49.5% |
| FY2019 | Dec 31, 2019 | $9.00M | – |
See a number that looks wrong?